Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
29,596,439
-
Total 13F shares
-
3,197,807
-
Share change
-
-94,493
-
Total reported value
-
$54,748,908
-
Price per share
-
$17.13
-
Number of holders
-
51
-
Value change
-
-$1,461,169
-
Number of buys
-
23
-
Number of sells
-
26
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q1 2019
As of 31 Mar 2019,
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,197,807 shares.
The largest 10 holders included
NEEDHAM INVESTMENT MANAGEMENT LLC, MORGAN STANLEY, RAYMOND JAMES & ASSOCIATES, FLAGSHIP HARBOR ADVISORS, LLC, WELLS FARGO & COMPANY/MN, COHEN & STEERS INC, WOLVERINE ASSET MANAGEMENT LLC, Invesco Ltd., BANK OF AMERICA CORP /DE/, and Advisor Group, Inc..
This page lists
51
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.